Gwenn Hansen Insider Trades & Stock Holdings

Chief Scientific Officer · Nurix Therapeutics, Inc. · Latest filing Jun 25, 2026

Gwenn Hansen, Chief Scientific Officer at Nurix Therapeutics, Inc. has 1 Form 4 trade on file since Jun 25, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($107.88K), net -$107.88K. Latest filing: disposed of 5.39K shares of $NRIX on Jun 25, 2026 at $20.

Trades on file

1

Open-market bought

$0

Open-market sold

$107.88K

Net open-market

-$107.88K

Latest filing

Jun 25, 2026

All insider trades by Gwenn Hansen

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 25, 2026	$NRIX	Sell (Open-market sale) 10b5-1	5.39K	$20	$107.88K			+6.7%	+4.3%		Chief Scientific Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Gwenn Hansen traded

• $NRIX

Frequently asked questions

Has Gwenn Hansen been buying or selling stock?

Gwenn Hansen has 0 open-market purchases and 1 open-market sale on file, net -$107.88K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Gwenn Hansen's latest insider trade?

disposed of 5.39K shares of $NRIX on Jun 25, 2026 at $20.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.